.Jonathan Villena MD shares the thoracic surgeons perspective of the combined procedure of robotic bronchoscopy and robotic thoracic surgery. 🚀 Interventional Pulmonology Symposium "The Era of Robotics" #RoboticsInHealthcare #PulmonologyAdvancements #ThoracicSurgery

Thank you ⁦American Cancer Society⁩ and ⁦CNN⁩ ⁦Wolf Blitzer⁩ for such an important update. We are getting better at treating most cancers. Yet the incidence of cancer has gone up in younger people. As always, screening is the key.⁦⁦ cnn.com/videos/health/…

fox26houston.com/video/1397520 American Cancer Society LungCancerAmerica LUNGevity Foundation

CNN en Español and American Cancer Society Por primera vez, la incidencia de cáncer ha superado los 2 millones de casos cada año. La buena noticia es que el 42% de estos cánceres son prevenibles cnnespanol.cnn.com/video/cancer-s…

Thank you NewsNation and American Cancer Society for the important data. The incidence of all cancers are expected to go up 77% by 2050 world wide. Troubling trend in incidence in younger people. Again, prevention is key and early detection is key! 42% of all cancer is preventable

Discover more about @JonVillenaM talk “CD8+ T Cell Clonal Dynamics in Response to ICB Therapy in Surgically Resectable NSCLC” for National Cancer Institute early career scientist spotlight research seminar series, as they drive progress in cancer prevention. events.cancer.gov/dcp/early-care…

Dr. Jonathan Villena-Vargas Explica que Cualquier Persona con Pulmones Puede Desarrollar Cáncer de Pulmón. Mira el video completo en el enlace. Jonathan Villena MD #CáncerDePulmón #SaludPulmonar bit.ly/4421IXa

.Jonathan Villena MD presented tonight on the critical role of the T cell response in the tumor draining lymph node of Neoadjuvant pd-1 treatment AATS

🎉EI is proud to support the translational research of Drs Mohammed Fouda (Mohammed Fouda, MD), Evi Giannakakou, Shahin Rafii & Jonathan Villena-Vargas (Jonathan Villena MD) with the Daedalus Fund for Innovation. Stay tuned for the intro of each award-winning technology!

.Jonathan Villena MD & Daedalus Fund recipients are pioneering advancements in translational studies to reach new stages. Dr. Villena is developing a new approach that leverages lymph-node-derived T cells engineered to fight solid tumors, targeting nsclc. innovation.weill.cornell.edu/news-events/da…

Dr. Villena-Vargas (Jonathan Villena MD) identified lymph-node-derived T cells that can overcome the “antigen escape” by solid tumors, a novel approach to treat NSCLC. Read more about all Daedalus Fund award-winning technologies👉: tinyurl.com/mttejke7

‼️Congratulations to my friend, colleague, and mentor, Dr. Laura Pinheiro!! There is no one more deserving— Laura is the embodiment of brilliance, kindness, and humility. 🥳🤩👏👏👏🙌🙌🙌 Weill Cornell Medicine Meyer Cancer Center General Internal Medicine Weill Cornell Medicine Population Health Sciences

Enjoyed hearing about the work friend/colleague Jonathan Villena MD is doing to understand T Cell clonal dynamics in response to immune checkpoint blockade therapy in #NSCLC 🫁🤩👏👏👏 Weill Cornell Medicine Cardiothoracic Surgery Weill Cornell Medicine Meyer Cancer Center Weill Cornell Medicine Pathology

Come hang out with a bunch of smart Mount Sinai Thoracic Oncology & Weill Cornell Medicine Cardiothoracic Surgery docs and learn about new data in lung cancer. Deborah Doroshow . Mount Sinai Hematology/Oncology Fellowship The Tisch Cancer Institute Jonathan Villena MD Christian Rolfo urldefense.proofpoint.com/v2/url?u=https…